Get started
SpectraCure ABSpectraCure ABSpectraCure AB

SpectraCure AB

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsSeasonals

Live chart


Full chart

Key stats


Market capitalization
‪6.60 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0134 EUR
Net income (FY)
‪−2.00 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪326.85 M‬
Beta (1Y)
−0.87

Employees


Employees (FY)
16
Change (1Y)
0
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About SpectraCure AB


Sector
Electronic Technology
Industry
Electronic Equipment/Instruments
CEO
Johannes Swartling
Website
spectracure.com
Headquarters
Lund
Founded
2003
ISIN
SE0007158118
FIGI
BBG00N9L91G4
SpectraCure AB engages in the research, development, and provision of equipment for cancer treatments. It focuses on cancer treatments using medical systems with laser light sources and reactive drugs, which are referred to as interstitial photodynamic therapy. The company was founded by Sune Roland Svanberg, Katarina Svanberg, and Stefan Andersson-Engels in March 2003 and is headquartered in Lund, Sweden.

Check out other big names from the same industry as 2OK.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SpectraCure AB stocks are traded under the ticker 2OK.
2OK reached its all-time high on Jul 16, 2019 with the price of 4.1300 EUR, and its all-time low was 0.0001 EUR and was reached on May 26, 2025. View more price dynamics on 2OK chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track SpectraCure AB financials in yearly and quarterly reports right on TradingView.
2OK net income for the last quarter is ‪−643.17 K‬ EUR, while the quarter before that showed ‪−579.14 K‬ EUR of net income which accounts for −11.06% change. Track more SpectraCure AB financial stats to get the full picture.
No, 2OK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 23, 2025, the company has 16 employees. See our rating of the largest employees — is SpectraCure AB on this list?
Like other stocks, 2OK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SpectraCure AB stock right from TradingView charts — choose your broker and connect to your account.